| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | Director | Common Stock | 28.9K | $195K | $6.74 | May 8, 2024 | Direct |
| ANAPTYSBIO, INC | Director | Common Stock | 2.04K | $47.1K | $23.16 | Jun 15, 2024 | Direct |
| Atreca, Inc. | PRESIDENT & CEO, Director | Class A Common Stock | 77.5K | $29K | $0.37 | Apr 11, 2024 | Direct |
| ANAPTYSBIO, INC | Director | Restricted Stock Unit | 0 | $0 | $23.16 | Jun 15, 2024 | Direct |
| CARGO Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 23.7K | Jun 4, 2024 | Direct | ||
| Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19.5K | May 8, 2024 | Direct | ||
| ANAPTYSBIO, INC | Director | Stock Option (right to buy) | 16.5K | Jan 3, 2024 | Direct | ||
| Atreca, Inc. | PRESIDENT & CEO, Director | Series A Junior Preferred Stock | 1 | Apr 11, 2024 | Direct | ||
| Seagen Inc. | Director | Common Stock | 0 | $229.00 | Dec 14, 2023 | Direct | |
| Seagen Inc. | Director | Restricted Stock Units | 0 | $229.00 | Dec 14, 2023 | Direct | |
| Seagen Inc. | Director | Stock Options (Right to Buy) | 0 | Dec 14, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO, INC | Jun 15, 2024 | 2 | $0 | 4 | Jun 18, 2024 | Director |
| CRGX | CARGO Therapeutics, Inc. | Jun 4, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
| TVTX | Travere Therapeutics, Inc. | May 8, 2024 | 2 | $0 | 4 | May 10, 2024 | Director |
| BCEL | Atreca, Inc. | Apr 11, 2024 | 1 | $0.01 | 4 | Apr 17, 2024 | PRESIDENT & CEO, Director |
| ANAB | ANAPTYSBIO, INC | Jan 3, 2024 | 2 | $0 | 4 | Jan 5, 2024 | Director |
| SGEN | Seagen Inc. | Dec 14, 2023 | 11 | -$6.64M | 4 | Dec 15, 2023 | Director |
| CRGX | CARGO Therapeutics, Inc. | Nov 9, 2023 | 1 | $0 | 4 | Nov 13, 2023 | Director |
| CRGX | CARGO Therapeutics, Inc. | Nov 9, 2023 | 0 | $0 | 3 | Nov 9, 2023 | Director |
| ANAB | ANAPTYSBIO, INC | Sep 15, 2023 | 4 | $0 | 4 | Sep 18, 2023 | Director |
| ANAB | ANAPTYSBIO, INC | Sep 15, 2023 | 0 | $0 | 3 | Sep 18, 2023 | Director |
| BCEL | Atreca, Inc. | Sep 1, 2023 | 1 | -$8.6K | 4 | Apr 3, 2024 | PRESIDENT & CEO, Director |
| SGEN | Seagen Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| TVTX | Travere Therapeutics, Inc. | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
| BCEL | Atreca, Inc. | Feb 9, 2023 | 1 | $0 | 4 | Feb 13, 2023 | President & CEO, Director |
| BCEL | Atreca, Inc. | Sep 2, 2022 | 1 | -$37.1K | 4 | Sep 20, 2022 | President & CEO, Director |
| BCEL | Atreca, Inc. | Jun 13, 2022 | 8 | $0 | 4 | Jun 15, 2022 | President & CEO, Director |
| SGEN | Seagen Inc. | May 13, 2022 | 2 | $0 | 4 | May 17, 2022 | Director |
| TVTX | Travere Therapeutics, Inc. | May 11, 2022 | 2 | $0 | 4 | May 12, 2022 | Director |
| BCEL | Atreca, Inc. | Dec 23, 2021 | 1 | $0 | 4 | Dec 28, 2021 | President & CEO, Director |
| BCEL | Atreca, Inc. | Sep 9, 2021 | 1 | $0 | 4 | Sep 13, 2021 | President & CEO, Director |
| TVTX | Travere Therapeutics, Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |
| SGEN | Seagen Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |